BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38702479)

  • 1. Prevalence and clinical implications of sarcopenia in breast cancer: a systematic review and meta-analysis.
    Jang MK; Park S; Raszewski R; Park CG; Doorenbos AZ; Kim S
    Support Care Cancer; 2024 May; 32(5):328. PubMed ID: 38702479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
    Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
    Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
    Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
    Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.
    Kurk S; Peeters P; Stellato R; Dorresteijn B; de Jong P; Jourdan M; Creemers GJ; Erdkamp F; de Jongh F; Kint P; Simkens L; Tanis B; Tjin-A-Ton M; Van Der Velden A; Punt C; Koopman M; May A
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):803-813. PubMed ID: 31094083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.
    Takenaka Y; Oya R; Takemoto N; Inohara H
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1122-1135. PubMed ID: 34337889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis.
    Jogiat UM; Bédard ELR; Sasewich H; Turner SR; Eurich DT; Filafilo H; Baracos V
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2630-2636. PubMed ID: 36151845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
    Shachar SS; Williams GR; Muss HB; Nishijima TF
    Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis.
    Jin Y; Ma X; Yang Z; Zhang N
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):697-705. PubMed ID: 36720459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
    Ubachs J; Ziemons J; Minis-Rutten IJG; Kruitwagen RFPM; Kleijnen J; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1165-1174. PubMed ID: 31389674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of sarcopenia with endocrine therapy toxicity in patients with early breast cancer.
    Aleixo GFP; Valente SA; Wei W; Moore HCF
    Breast Cancer Res Treat; 2022 Nov; 196(2):323-328. PubMed ID: 36114941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Sarcopenia Interventions for Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-analysis.
    Jang MK; Park C; Tussing-Humphreys L; Fernhall B; Phillips S; Doorenbos AZ
    Cancer Nurs; 2023 Mar-Apr 01; 46(2):E81-E90. PubMed ID: 34054070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
    Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review.
    Zeng X; Zhang L; Zhang Y; Jia S; Lin T; Zhao X; Huang X
    Front Oncol; 2023; 13():1308544. PubMed ID: 38162495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal Muscle Mass Change During Chemotherapy: A Systematic Review and Meta-analysis.
    Jang MK; Park C; Hong S; Li H; Rhee E; Doorenbos AZ
    Anticancer Res; 2020 May; 40(5):2409-2418. PubMed ID: 32366384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis, prevalence, and outcomes of sarcopenia in kidney transplantation recipients: A systematic review and meta-analysis.
    Zhang JZ; Shi W; Zou M; Zeng QS; Feng Y; Luo ZY; Gan HT
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):17-29. PubMed ID: 36403578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
    da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
    Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
    Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
    Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis.
    Duarte MP; Almeida LS; Neri SGR; Oliveira JS; Wilkinson TJ; Ribeiro HS; Lima RM
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):501-512. PubMed ID: 38263952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.